Azathioprine in the treatment of refractory rheumatoid arthritis
O'Reilly, T.J.
Irish Medical Journal 70(11): 344-346
1977
ISSN/ISBN: 0332-3102 PMID: 893045 Document Number: 111061
Document emailed within 1 workday
Related Documents
Kerstens, P.J.; Boerbooms, A.M.; Jeurissen, M.E.; de Graaf, R.; Mulder, J.; van de Putte, L.B. 2000: Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine Journal of Rheumatology 27(5): 1148-1155Keesal, N.; Wasserman, M.J.; Bookman, A.; Lapp, V.; Weber, D.A.; Keystone, E.C. 1999: Thalidomide in the treatment of refractory rheumatoid arthritis Journal of Rheumatology 26(11): 2344-2347
Krel', A.A.; Kanevskaia, M.Z.; Rashchupkina, Z.P.; Bolotin, E.V.; Chichasova, N.V. 1981: Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects Terapevticheskii Arkhiv 53(7): 86-96
Chevallard, M.; Venegoni, C.; Scaramuzza, D.; Carrabba, M.; Colombo, B. 1988: Pilot study on the use of captopril in treatment of refractory rheumatoid arthritis Giornale di Clinica Medica 69(6-7): 443-445; 447
Wendt, T.; Eidner, T.; Bräunig, E.; Hein, G. 1999: Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis European Journal of Medical Research 4(10): 442-448
Lin, Y.T.; Yang, Y.H.; Tsai, M.J.; Chiang, B.L. 2000: Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis Journal of the Formosan Medical Association 99(4): 330-335
Nakamura, H.; Yoshino, S.; Ishiuchi, N.; Fujimori, J.; Kanai, T.; Nishimura, Y. 1997: Outcome of radical multiple synovectomy as a novel surgical treatment for refractory rheumatoid arthritis: implication of HLA-DRB1*0405 in post-operative results Clinical and Experimental Rheumatology 15(1): 53-57
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Allanore, Y.; Sellam, J.; Batteux, F.; Job Deslandre, C.; Weill, B.; Kahan, A. 2004: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clinical and Experimental Rheumatology 22(6): 756-758
Ran, W-bin.; Ouyang, Q.; Dong, L-feng.; Xue, L-yun. 2012: A retrospective analysis of azathioprine in the treatment of 24 patients with refractory ulcerative colitis Zhonghua Nei Ke Za Zhi 51(8): 613-617
Maksymowych, W.P.; Aviña-Zubieta, A.; Luong, M.; Russell, A.S. 1996: High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy Clinical and Experimental Rheumatology 14(6): 657-660
Grana, J.; Mahia, I.V.; Meizoso, M.-O.S.; Vazquez, T. 2008: Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis) Clinical and Experimental Rheumatology 26(2): 384-385
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
De Bosset, P.L.; Biter, T. 1973: Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. a prospective investigation Schweizerische Medizinische Wochenschrift 103(33): 1153-1158
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683